Reading ATRC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ATRC free→Reading ATRC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ATRC free→QuarterlyIQ Insights · ATRC
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. At the AtriCure, Inc. (the “Company”) 2026 Annual Meeting of Stockholders held on May 18, 2026 (“Annual Meeting”), the stockholders of the Company approved an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan (the “Amended 2023 Plan”). The 2023 Stock Incentive Plan was previously approved and amended to increase the number of shares availab…
Results of Operations and Financial Condition. On May 6, 2026, AtriCure, Inc. issued a press release regarding its financial results for the first quarter ended March 31, 2026. The Company held a conference call on May 5, 2026 at 4:30 p.m. Eastern Time to discuss the financial results. A copy of the press release, as corrected, is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information in
Results of Operations and Financial Condition. On May 5, 2026 , AtriCure, Inc. issued a press release regarding its financial results for the first quarter ended March 31, 2026. The Company will hold a conference call on May 5, 2026 at 4:30 p.m. Eastern Time to discuss the financial results. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information in
Results of Operations and Financial Condition. On February 17, 2026 , AtriCure, Inc. issued a press release regarding its financial results for the fourth quarter and full-year ended December 31, 2025. The Company will hold a conference call on February 17, 2026 at 4:30 p.m. Eastern Time to discuss the financial results. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information in
Results of Operations and Financial Condition. On January 12, 2026, AtriCure issued a press release announcing its preliminary financial results for the fourth quarter and full year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
Entry into a Material Definitive Agreement. On January 9, 2026 (the “ Closing Date ”), AtriCure, Inc. (the “ Company ”) and its wholly owned subsidiary, AtriCure, LLC (together with the Company, the “ Borrowers ”), entered into a First Amendment (“ First Amendment ”) to Credit Agreement (as amended, the “ Credit Agreement ”) among the Borrowers, JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “ Administrative Agent ”), JPMorgan Chase Bank, N.A., as bookrunner and lea…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth under
Results of Operations and Financial Condition. On October 29, 2025 , AtriCure, Inc. issued a press release regarding its financial results for the third quarter ended September 30, 2025. The Company will hold a conference call on October 29, 2025 at 4:30 p.m. Eastern Time to discuss the financial results. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information in
Results of Operations and Financial Condition. On October 29, 2025 , AtriCure, Inc. issued a press release regarding its financial results for the third quarter ended September 30, 2025. The Company will hold a conference call on October 29, 2025 at 4:30 p.m. Eastern Time to discuss the financial results. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information in
Results of Operations and Financial Condition. On July 29, 2025 , AtriCure, Inc. issued a press release regarding its financial results for the second quarter ended June 30, 2025. The Company will hold a conference call on July 29, 2025 at 4:30 p.m. Eastern Time to discuss the financial results. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information in
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. At the AtriCure, Inc. (the “Company”) 2025 Annual Meeting of Stockholders held on May 19, 2025 (“Annual Meeting”), the stockholders of the Company approved an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan (the “Amended 2023 Plan”). The 2023 Stock Incentive Plan was previously approved and amended to increase the number of shares availab…
Results of Operations and Financial Condition. On April 29, 2025 , AtriCure, Inc. issued a press release regarding its financial results for the first quarter ended March 31, 2025. The Company will hold a conference call on April 29, 2025 at 4:30 p.m. Eastern Time to discuss the financial results. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information in
Results of Operations and Financial Condition. On February 12, 2025 , AtriCure, Inc. issued a press release regarding its financial results for the fourth quarter and full-year ended December 31, 2024. The Company will hold a conference call on February 12, 2025 at 4:30 p.m. Eastern Time to discuss the financial results. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information in
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.